BlackRock Advisors’s Exact Sciences EXAS Stock Holding History

BlackRock Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.67M	Buy	200,079 +2,833	+1%	+$45.7K	﹤0.01%	1383
2016 Q3	$3.66M	Buy	197,246 +113,516	+136%	+$2M	﹤0.01%	1226
2016 Q2	$1.03M	Buy	83,730 +40,321	+93%	+$304K	﹤0.01%	1755
2016 Q1	$293K	Sell	43,409 -15,078	-26%	-$96.5K	﹤0.01%	2358
2015 Q4	$540K	Sell	58,487 -71,935	-55%	-$669K	﹤0.01%	2037
2015 Q3	$2.35M	Buy	130,422 +1,269	+1%	+$29.1K	﹤0.01%	1310
2015 Q2	$3.84M	Buy	129,153 +41,667	+48%	+$1.05M	﹤0.01%	1066
2015 Q1	$1.93M	Buy	87,486 +486	+0.6%	+$12.3K	﹤0.01%	1250
2014 Q4	$2.39M	Buy	87,000 +16,782	+24%	+$408K	﹤0.01%	1144
2014 Q3	$1.36M	Buy	70,218 +14,932	+27%	+$274K	﹤0.01%	1295
2014 Q2	$942K	Sell	55,286 -6,729	-11%	-$92.7K	﹤0.01%	1550
2014 Q1	$879K	Buy	62,015 +15,627	+34%	+$211K	﹤0.01%	1631
2013 Q4	$545K	Buy	46,388 +3,258	+8%	+$37.4K	﹤0.01%	1976
2013 Q3	$509K	Buy	43,130 +4,383	+11%	+$56.2K	﹤0.01%	1893
2013 Q2	$539K	Buy	+38,747	New	+$421K	﹤0.01%	1772

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BlackRock Advisors's EXAS Position: Q4 2016 in Review

BlackRock Advisors increased its Exact Sciences (EXAS) stake by 1.4% in Q4 2016, buying an estimated $45.7K and bringing the position to 200,079 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

BlackRock Advisors first reported a position in EXAS in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.84M in Q2 2015. 222 funds tracked by Wall St. Rank hold EXAS as of Q4 2016.

BlackRock Advisors held 200,079 shares of Exact Sciences worth $2.67M as of Q4 2016.
BlackRock Advisors bought 2,833 Exact Sciences shares in Q4 2016, an estimated $45.7K.
Exact Sciences made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1383 holding.
BlackRock Advisors first reported a position in Exact Sciences in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Exact Sciences position peaked at $3.84M in Q2 2015.
222 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.